PARNAX LAB
|
The Current P/E Ratio of PARNAX LAB is 14.93.
Share Price | ₹114.5 | May 18,2024 |
Market Cap | ₹131.6 Cr | |
Earnings-TTM | ₹8.8 Cr | TTM-Consolidated Results |
Price/Earnings | 14.93x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of PARNAX LAB
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹131.6 Cr] as on May 18,2024
(/) Earnings [ ₹8.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 14.93x ]
Thus, for PARNAX LAB , the investors are currently willing to pay 14.93 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PARNAX LAB !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PARNAX LAB over the last five years.
Historical PE (Price/Earnings) ratio chart of PARNAX LAB
PE Ratio Performance Analysis for PARNAX LAB
- PARNAX LAB 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 6.26x.
- PARNAX LAB 's operated at median p/e ratio of 6.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PARNAX LAB 's p/e ratio peaked in Mar2022 at 15.68x.
- PARNAX LAB 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does PARNAX LAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
PARNAX LAB | 8.82 | 14.93 | 131.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.82 | 367,290.0 |
CIPLA LTD | 4,155.31 | 27.28 | 113,357.0 |
DR REDDYS LABORATORIES LTD | 5,563.20 | 17.44 | 97,001.5 |
ZYDUS LIFESCIENCES LTD | 3,831.40 | 29.01 | 111,134.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 75.37 | 104,235.0 |
MANKIND PHARMA LTD | 1,926.55 | 43.91 | 84,596.1 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 61.28 | 91,556.3 |
LUPIN LTD | 1,935.57 | 39.09 | 75,652.2 |
AUROBINDO PHARMA LTD | 2,777.89 | 25.37 | 70,467.9 |
ABBOTT INDIA LTD | 1,201.22 | 47.13 | 56,616.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PARNAX LAB 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 14.93x |
Max industry PE | 75.37x |
Median industry PE | 39.09x |
Average industry PE | 38.33x |
You may also like the below Video Courses